Physician profile
Kevin Alan Williams
NPI 1316351836
$11,211.01
in general payments reported to CMS, 2019-2025
14 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Pediatric Orthopaedic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $618 · 2020: $631 · 2021: $1,319 · 2022: $2,602 · 2023: $5,600 · 2024: $130 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,547 · Consulting Fee: $2,500 · Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,547.44 |
| Consulting Fee | $2,500.00 |
| Food and Beverage | $994.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Prime Surgical, LLC | $5,505.97 | 2020-2023 | |
| Orthopediatrics Corp. | $3,903.83 | 2022-2023 | |
| Medical Device Business Services, INC. | $423.95 | 2019 | |
| Arthrex, INC. | $382.80 | 2023 | |
| Depuy Synthes Sales INC. | $222.77 | 2019-2023 | Na |
| Medtronic, INC. | $156.27 | 2025 | |
| Siemens Medical Solutions USA, INC. | $151.20 | 2023-2025 | Varian Cryocare Touch System, Naeotom Alpha |
| Linvatec Corporation | $137.82 | 2025 | Biobrace 23mm |
| Teva Pharmaceuticals USA, INC. | $130.24 | 2024 | Austedo Xr |
| Orthofix Medical, INC. | $58.00 | 2019 | |
| Ermi LLC | $55.17 | 2022 | |
| Biocomposites INC | $39.38 | 2023 | Stimulan |
| Portola Pharmaceuticals, LLC | $27.21 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $16.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.